Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI‐MS) Analyses

Abstract: We previously reported that lysophosphatidic acid (LPA) represents a potential biomarker for ovarian and other gynecologic cancers. To further improve the accuracy and potentially increase the sensitivity and specificity of the assay, we developed an electrospray ionization mass spectrometry (ESI‐MS)‐based method to analyze LPA and related lysophospholipids. LPA, lysophosphatidylinositol (LPI), lysophosphatidylserine (LPS), and lysophosphatidylcholine (LPC) could be detected with high sensitivity (in low pmol range) using this method. Standard curves were established for quantitative analysis. LPA and closely related lysophospholipids isolated from thin‐layer chromatography (TLC) plates were analyzed directly by ESI‐MS. This ESI‐MS‐based assay allows simultaneous detection and quantitation of all different species of LPAs and LPIs in a sample over a range of at least 5–300 pmol. Moreover, this test was at least 50 times more sensitive when a multiple reaction monitoring (MRM) mode was used. Using these protocols in a limited set of analyses, we found that both LPA and LPI were elevated in patients with ovarian cancer.

[1]  S. Tanaka,et al.  Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. , 1994, The American journal of physiology.

[2]  R. Miledi,et al.  A factor that activates oscillatory chloride currents in Xenopus oocytes copurifies with a subfraction of serum albumin. , 1991, The Journal of biological chemistry.

[3]  R. Miledi,et al.  Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. , 1992, The Journal of biological chemistry.

[4]  E. Lapetina,et al.  Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid. , 1985, The Biochemical journal.

[5]  R. Bast,et al.  The CA 125 tumour-associated antigen: a review of the literature. , 1989, Human reproduction.

[6]  R. Bast,et al.  Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.

[7]  A. Tuininga,et al.  Isoprenoid-mediated changes in the glycerophospholipid molecular species of the sterol auxotrophic fungus Lagenidium giganteum. , 1995, Microbiology.

[8]  Xianlin Han,et al.  Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Weintraub,et al.  Electrospray ionization for analysis of platelet-activating factor. , 1991, Rapid Communications in Mass Spectrometry.

[10]  G. Mills,et al.  Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  Y. Oda,et al.  Simultaneous quantitative determination method for sphingolipid metabolites by liquid chromatography/ionspray ionization tandem mass spectrometry. , 1997, Analytical biochemistry.

[12]  W. Collins,et al.  SCREENING FOR EARLY OVARIAN CANCER , 1988, The Lancet.

[13]  W. Creasman,et al.  Ovarian cancer screening. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M Markman,et al.  Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.

[15]  M. Palmer,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1982, British Journal of Cancer.

[16]  G. Mills,et al.  Lysophospholipids activate ovarian and breast cancer cells. , 1995, The Biochemical journal.

[17]  M. Triggiani,et al.  Antigen-induced generation of lyso-phospholipids in human airways , 1996, The Journal of experimental medicine.

[18]  Wei Sha,et al.  Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.

[19]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.

[20]  I. Fahrenfort,et al.  The bioactive phospholipid lysophosphatidic acid is released from activated platelets. , 1993, The Biochemical journal.

[21]  A. Karlsson,et al.  Molecular species of sphingomyelin: determination by high-performance liquid chromatography/mass spectrometry with electrospray and high-performance liquid chromatography/tandem mass spectrometry with atmospheric pressure chemical ionization. , 1998, Journal of mass spectrometry : JMS.

[22]  J. Turk,et al.  Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: comparison to other tissues and implications for membrane fusion in insulin exocytosis. , 1998, Biochemistry.

[23]  C. Hoischen,et al.  Structural characterization of molecular phospholipid species in cytoplasmic membranes of the cell wall-less Streptomyces hygroscopicus L form by use of electrospray ionization coupled with collision-induced dissociation mass spectrometry , 1997, Journal of bacteriology.

[24]  B. Karlan,et al.  Early detection and risk reduction for familial gynecologic cancers. , 1998, Clinical obstetrics and gynecology.

[25]  R. Gross,et al.  Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. , 1996, Biochemistry.

[26]  G. Mills,et al.  Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine(lysoPC) in ovarian cancer patients , 1997, International journal of cancer.

[27]  F. Hsu,et al.  Formation of lithiated adducts of glycerophosphocholine lipids facilitates their identification by electrospray ionization tandem mass spectrometry , 1998, Journal of the American Society for Mass Spectrometry.

[28]  A. Tuininga,et al.  Identification of molecular species of glycerophospholipids and sphingomyelin using electrospray mass spectrometry. , 1994, Journal of lipid research.

[29]  J. Kerwin,et al.  Identification of fatty acids by electrospray mass spectrometry and tandem mass spectrometry. , 1996, Journal of mass spectrometry : JMS.

[30]  R. Bast,et al.  Elevation of multiple serum markers in patients with stage I ovarian cancer. , 1993, Journal of the National Cancer Institute.

[31]  R. Bast,et al.  Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection , 1995, Cancer.

[32]  P. Schwartz,et al.  Is early detection of ovarian cancer possible? , 1995, Annals of medicine.